Summary
Quest Diagnostics Incorporated (DGX) held an Investor Day on November 11, 2016, where management provided forward-looking guidance and strategic updates. A key takeaway for investors is the company's expectation of annual growth in revenues and earnings for the three-year period ending December 31, 2020. This optimism is supported by strategic initiatives focused on accelerating growth and driving operational excellence, including an expansion of their retail presence within Safeway stores. Furthermore, the company reaffirmed its commitment to cost savings through the Invigorate Program, targeting a run rate of $1.3 billion in cost savings by the end of 2017, with significant progress already achieved. The dividend increase announced alongside these updates also signals confidence in the company's financial health and commitment to shareholder returns.
Key Highlights
- 1Projected annual revenue and earnings growth for the period ending December 31, 2020.
- 2Reaffirmed 2016 financial expectations.
- 3Plans to significantly expand retail presence in Safeway stores, reaching over 50 by end of 2016 and 200 by end of 2017.
- 4Updated the Invigorate Program with expected 2016 savings of approximately $200 million, and a reaffirmed target of $1.3 billion in run rate cost savings by the end of 2017.
- 5Announced a 12.5% increase in quarterly dividend to $0.45 per share, effective early 2017, raising the annual rate to $1.80 per share.
- 6Outlined a two-point strategy: Accelerate Growth and Drive Operational Excellence, by categorizing services into General Diagnostics, Advanced Diagnostics, and Diagnostic Services.
- 7Reported positive organic revenue growth trends since 2013, turning positive in 2015 and continuing into 2016.